Medication info
Vipozene 5/160mg (Amlodipine Besilate, Valsartan)

Vipozene 5/160mg (Amlodipine Besilate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Dark yellow oval film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201603065 · Approved 2016.05.30 · Insurance code 694001180

Summary

Main use
Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication is used to more effectively lower blood pressure in patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy using either amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual ingredients (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual ingredients as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg as monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg as monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg as monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients undergoing dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; its use is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any of the ingredients in this medication, pregnant or nursing women, patients with severe kidney or liver disease, and those with a history of specific heart diseases or angioedema should not take this medication. Patients with low body sodium or fluid levels must manage their condition before taking this medication, as low blood pressure symptoms may occur during use, requiring careful monitoring. Patients with high potassium levels or taking potassium-containing medications should frequently check their potassium levels. Patients with weak kidney function or kidney transplant recipients should use this medication cautiously, as it may affect kidney function. Patients with heart failure or those recovering from a myocardial infarction should closely monitor kidney function when taking this medication and manage to prevent excessive drops in blood pressure. Dizziness or fatigue may occur while taking this medication, necessitating caution when driving or operating machinery. This medication may interact with other drugs, particularly potassium supplements, diuretics, NSAIDs, lithium, simvastatin, and CYP3A4 inhibitors, so consultation with healthcare professionals is advised before concurrent use. Overdosage may lead to low blood pressure or heart problems, so it is essential to strictly adhere to the prescribed dosage and seek medical attention immediately if any abnormal symptoms arise. This medication is not recommended for children under 18 years of age, and while the same dosage can be used for elderly individuals, their condition should be monitored closely.

Side effects

  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • positional dizziness
  • paresthesia
Show 117 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pain in the throat and larynx
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • hyperhidrosis
  • rash
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasm
  • fatigue
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • localized edema
  • facial edema
  • peripheral edema
  • tiredness
  • flushing
  • weakness
  • facial flushing
  • hemoglobin reduction
  • hematocrit reduction
  • neutropenia
  • thrombocytopenia
  • serum sickness-type hypersensitivity
  • increased serum potassium
  • vasculitis
  • elevated liver function tests
  • angioedema
  • vesicular dermatitis
  • myalgia
  • renal failure
  • kidney damage
  • elevated serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremor
  • sensory impairment
  • taste disturbance
  • peripheral neuropathy
  • excessive muscle tone
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • dyspnea
  • rhinitis
  • vomiting
  • indigestion
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • urination disorders
  • nocturnal enuresis
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • elevated liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • nervous irritability
  • sensory impairment
  • Stevens-Johnson syndrome
  • chest pain
  • weight gain
  • arthralgia
  • skeletal pain
  • rhabdomyolysis
  • gingival hyperplasia
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent the ingress of air or moisture. It is advisable to maintain a storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow oval film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.